000			01904 a2200505 4500
005			20250516052054.0
264		0	_c20111222
008			201112s 0 0 eng d
022			_a1744-7593
024	7		_a10.1517/17425247.2011.608350 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchertz, Joan C
245	0	0	_aThe redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testing. _h[electronic resource]
260			_bExpert opinion on drug delivery _cSep 2011
300			_a1111-20 p. _bdigital
500			_aPublication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAttitude of Health Personnel
650	0	4	_aEquipment Design
650	0	4	_aFemale
650	0	4	_aFertilization in Vitro
650	0	4	_aFollicle Stimulating Hormone, Human _xadministration & dosage
650	0	4	_aGermany
650	0	4	_aGlycoprotein Hormones, alpha Subunit _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInfertility, Female _xdrug therapy
650	0	4	_aInjections, Subcutaneous _xadverse effects
650	0	4	_aMaterials Testing
650	0	4	_aMedication Errors _xprevention & control
650	0	4	_aMiddle Aged
650	0	4	_aNurses _xpsychology
650	0	4	_aPatient Education as Topic
650	0	4	_aPatient Satisfaction
650	0	4	_aPilot Projects
650	0	4	_aRecombinant Proteins _xadministration & dosage
650	0	4	_aRisk Assessment
650	0	4	_aSelf Administration _xadverse effects
650	0	4	_aSurveys and Questionnaires
700	1		_aSaunders, Helen
700	1		_aHecker, Clara
700	1		_aLang, Barbara
700	1		_aArriagada, Pablo
773	0		_tExpert opinion on drug delivery _gvol. 8 _gno. 9 _gp. 1111-20
856	4	0	_uhttps://doi.org/10.1517/17425247.2011.608350 _zAvailable from publisher's website
999			_c21087094 _d21087094